Severity of bulimia nervosa and its impact on treatment outcome
- 321 Downloads
Despite the burgeoning research in the aetiology of bulimic pathology, bulimia nervosa (BN) remains a serious eating disorder (ED) condition characterized by severe comorbid psychopathology, psychosocial impairment, and significant rates of medical complications [1, 2, 3, 4, 5, 6, 7, 8], underscoring the need for successful treatment options [2, 4]. Several systematic and meta-analytic reviews of the literature have given an important update on the extant treatments of BN [2, 9, 10, 11], also outlining the evidence about predictors of treatment outcome [11, 12, 13]. These valuable reviews can possibly be complemented by recent empirical evidence on the severity of BN, as defined by the most recent (fifth) edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , and its impact on treatment outcome.
BN is characterized by substantial within-diagnosis phenotypical heterogeneity, such that different individuals with the same disorder may exhibit variation in terms...
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study, formal consent is not required.
- 3.Dakanalis A, Carrà G, Calogero R, Zanetti MA, Gaudio S, Caccialanza R, Riva G, Clerici M (2015) Testing the cognitive-behavioural maintenance models across DSM-5 bulimic-type eating disorder diagnostic groups: a multi-study. Eur Arch Psychiatry Clin Neurosci 265(8):663–776. doi: 10.1007/s00406-014-0560-2 CrossRefPubMedGoogle Scholar
- 7.Ágh T, Kovács G, Supina D, Pawaskar M, Herman BK, Vokó Z, Sheehan DV (2016) A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder. Eat Weight Disord 21(3):353–364. doi: 10.1007/s40519-016-0264-x CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Dakanalis A, Bartoli F, Caslini M, Crocamo C, Zanetti MA, Riva G, Clerici M, Carrà G (2016) Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment. Eur Arch Psychiatry Clin Neurosci. doi: 10.1007/s00406-016-0712-7 CrossRefPubMedGoogle Scholar
- 17.National Institute for Clinical Excellence (2017) Eating disorders: recognition and treatment. British Psychological Society and Gaskell. https://www.nice.org.uk/guidance/ng69. Accessed 5 July 2017
- 19.Smith KE, Ellison JM, Crosby RD, Engel SG, Mitchell JE, Crow SJ, Peterson CB, Le Grange D, Wonderlich SA (2017) The validity of DSM-5 severity specifiers for anorexia nervosa, bulimia nervosa, and binge-eating disorder. Int J Eat Disord. doi: 10.1002/eat.22739 CrossRefPubMedPubMedCentralGoogle Scholar
- 20.American Psychiatric Association (2006) Treatment of patients with eating disorders, third edition. Am J Psychiatry 163(7 Suppl):4–54Google Scholar
- 21.Aigner M, Treasure J, Kaye W, Kasper S, WFSBP Task Force On Eating Disorders (2011) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry 12(6):400–443. doi: 10.3109/15622975.2011.602720 CrossRefPubMedGoogle Scholar